Table of Contents
• Dermatophytic Onychomycosis overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Dermatophytic Onychomycosis Market
• Global Epidemiology of Dermatophytic Onychomycosis Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Dermatophytic Onychomycosis Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Dermatophytic Onychomycosis (2013-2023)
• Table 7: Dermatophytic Onychomycosis Global Market (USD Millions), (2013-2015)
• Table 8: Dermatophytic Onychomycosis Global Market (USD Millions), (2016-2023)
• Table 9: Dermatophytic Onychomycosis US Market (USD Millions), (2013-2015)
• Table 10: Dermatophytic Onychomycosis US Market (USD Millions), (2016-2023)
• Table 11: Dermatophytic Onychomycosis Germany Market (USD Millions), (2013-2015)
• Table 12: Dermatophytic Onychomycosis Germany Market (USD Millions), (2016-2023)
• Table 13: Dermatophytic Onychomycosis United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Dermatophytic Onychomycosis United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Dermatophytic Onychomycosis France Market (USD Millions), (2013-2015)
• Table 16: Dermatophytic Onychomycosis France Market (USD Millions), (2016-2023)
• Table 17: Dermatophytic Onychomycosis Italy Market (USD Millions), (2013-2015)
• Table 18: Dermatophytic Onychomycosis Italy Market (USD Millions), (2016-2023)
• Table 19: Dermatophytic Onychomycosis Spain Market (USD Millions), (2013-2015)
• Table 20: Dermatophytic Onychomycosis Spain Market (USD Millions), (2016-2023)
• Table 21: Dermatophytic Onychomycosis Japan Market (USD Millions), (2013-2015)
• Table 22: Dermatophytic Onychomycosis Japan Market (USD Millions), (2016-2023)
• Table 23: Dermatophytic Onychomycosis ROW Market (USD Millions), (2013-2015)
• Table 24: Dermatophytic Onychomycosis ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Dermatophytic Onychomycosis Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Dermatophytic Onychomycosis (2013-2023)
• Figure 3: Dermatophytic Onychomycosis Global Market (USD Millions), (2013-2015)
• Figure 4: Dermatophytic Onychomycosis Global Market (USD Millions), (2016-2023)
• Figure 5: Dermatophytic Onychomycosis US Market (USD Millions), (2013-2015)
• Figure 6: Dermatophytic Onychomycosis US Market (USD Millions), (2016-2023)
• Figure 7: Dermatophytic Onychomycosis Germany Market (USD Millions), (2013-2015)
• Figure 8: Dermatophytic Onychomycosis Germany Market (USD Millions), (2016-2023)
• Figure 9: Dermatophytic Onychomycosis United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Dermatophytic Onychomycosis United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Dermatophytic Onychomycosis France Market (USD Millions), (2013-2015)
• Figure 12: Dermatophytic Onychomycosis France Market (USD Millions), (2016-2023)
• Figure 13: Dermatophytic Onychomycosis Italy Market (USD Millions), (2013-2015)
• Figure 14: Dermatophytic Onychomycosis Italy Market (USD Millions), (2016-2023)
• Figure 15: Dermatophytic Onychomycosis Spain Market (USD Millions), (2013-2015)
• Figure 16: Dermatophytic Onychomycosis Spain Market (USD Millions), (2016-2023)
• Figure 17: Dermatophytic Onychomycosis Japan Market (USD Millions), (2013-2015)
• Figure 18: Dermatophytic Onychomycosis Japan Market (USD Millions), (2015-2023)
• Figure 19: Dermatophytic Onychomycosis ROW Market (USD Millions), (2013-2015)
• Figure 20: Dermatophytic Onychomycosis ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Anacor Pharmaceuticals Inc.
• Celtic Pharmaceutical Holdings L.P.
• Genelabs Technologies Inc.
• Hisamitsu Pharmaceutical Co. Inc.
• Janssen Biotech Inc.
• Mayne Pharma Ltd.
• Merck & Co. Inc.
• NanoBio Corp.
• Novartis International AG
• Palau Pharma S.A.
• Pfizer Inc.
• Promius Pharma LLC
• Stiefel laboratories Inc.
• Topica Pharmaceuticals Inc.
• Valeant Pharmaceuticals International
【レポートのキーワード】
皮膚糸爪真菌症
【免責事項】
https://www.marketreport.jp/reports-disclaimer